Uncemented Reverse Total Shoulder Arthroplasty for Proximal Humerus Fractures

Overview

About this study

The aim of this protocol is to determine clinical, functional, radiographic, and survival outcomes in patients undergoing an uncemented reverse total shoulder arthroplasty for a proximal humerus fracture.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients who underwent a reverse total shoulder arthroplasty for a 3- or 4-part proximal humerus fracture between January 1, 2004 to the present/ Patient record must contain post-operative and follow-up radiological imaging, adequate clinical information.
Patients ≥ 18 years of age

Exclusion Criteria:

Patients < 18 years of age

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator John Sperling, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

John Sperling, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials